Alteon begins SAPPHIRE trial of ALT-711 for treatment of isolated systolic hypertension July 10, 2001
First nonpeptide protease inhibitor effective in patients failing PI-containing regimens July 10, 2001
Pharmacological profile of dual TxA2 antagonist and Tx synthase inhibitor discussed at ISTH July 10, 2001
Xenova receives FDA approval to resume clinical trials with anticocaine addiction vaccine July 10, 2001
RSS